Summary:
This study is evaluating if an additional dose of an Omicron specific COVID-19 booster is safe and how they may affect the immune system. Participants will receive a single vaccination, have 9 in-person visits, and their total participation will last around 12 months. Participants will be compensated for their time and expenses related to their study participation.
Qualified Participants Must:
• Fully vaccinated and boosted with a FDA-authorized or approved COVID-19 vaccine
•
Live in the DC, MD, or VA area
•
Are between the ages of 18 to 49
•
Are in good general health
Qualified Participants May Receive:
Participants will receive a single dose of an original COVID-19 Omicron specific variant vaccine.